Latham & Watkins Advises on Danimer Scientific’s Upsized US$200 Million Convertible Senior Notes Offering

Firm represents the initial purchasers in offering by the bioplastics company focused on the development and production of biodegradable materials.

December 17, 2021

Danimer Scientific, Inc., a leading next generation bioplastics company focused on the development and production of biodegradable materials, has announced the pricing of its offering of US$200,000,000 aggregate principal amount of 3.250% convertible senior notes due 2026 in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933. The offering size was increased from the previously announced offering size of US$175,000,000 aggregate principal amount of notes. The issuance and sale of the notes are scheduled to settle on December 21, 2021, subject to customary closing conditions. Danimer also granted the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional US$40,000,000 aggregate principal amount of notes.

Latham & Watkins LLP represents the initial purchasers in the offering with a capital markets team led by partners Greg Rodgers, Erika Weinberg, Marc Jaffe, and Ian Schuman, with associates Shawn Quinn, Alexandra Kustra, and Kevin Zhang. Advice was also provided on equity derivatives matters by partner Catherine Lee, with associates Eric Rice, Paul Lau, and Yi Wei; on intellectual property matters by partner Jeffrey Tochner, with associate Dewey Kang; on environmental matters by partner James Barrett, with associate Phil Sandick; and on tax matters by partner Bora Bozkurt, with Jacob Nagelberg.

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.